Overview

Nebulized Magnesium Sulfate as an Adjunct to Standard Therapy in Asthma Exacerbation

Status:
Unknown status
Trial end date:
2018-01-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to investigate the effectiveness of nebulized magnesium sulfate in patient with moderate to severe asthma exacerbation in pediatric emergency
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Hospital General Naval de Alta Especialidad - Escuela Medico Naval
Treatments:
Albuterol
Bromides
Ipratropium
Magnesium Sulfate
Methylprednisolone
Methylprednisolone acetate
Methylprednisolone Hemisuccinate
Prednisolone
Prednisolone acetate
Prednisolone hemisuccinate
Prednisolone phosphate
Criteria
Inclusion Criteria:

- Clinical diagnosis of moderate or severe asthma exacerbations

- 2 to 15 years old.

- Served in the pediatric emergency department of naval high specialty General Hospital
from September to December 2015.

- Signing the consent by the parents.

Exclusion Criteria:

- Coexistence of lung disease.

- Severe kidney disease.

- Severe liver disease.

- Pregnancy.

- Known previous reaction to magnesium.

- Parents who have not signed the agreement.

- Patients without a clinical history of asthma.

- Clinical diagnosis of mild asthma attack.

- Previously included in the study.

- Presence of comorbidities that endanger the patient's life.

- The patient has clinical or gasometric criteria for advanced airway management.

- Life-threatening symptoms.